ArticleNeurology and therapy2020

A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis.

Michelle Allan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.